Max Healthcare Institute Fair Value
Max Healthcare Institute (MAXHEALTH) average fair value is ₹876.6 across 5 valuation models — P/E Based Valuation, Price-to-Sales Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Discounted Cash Flow (DCF), vs a current market price of ₹951.7 (-7.89%), fair value range ₹66.72–₹3655.48. For live price and a broader fundamental view, visit MAXHEALTH stock price BSE.
Fair Value Analysis Export
MAXHEALTH Fair Value vs Current Price — Valuation Summary
MAXHEALTH average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, Price-to-Sales Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Discounted Cash Flow (DCF). Explore Max Healthcare Institute intrinsic worth to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
Price-to-Sales Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Discounted Cash Flow (DCF)
MAXHEALTH Fair Value Analysis — Data Sources & Coverage
Max Healthcare Institute financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine MAXHEALTH quarterly performance for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
MAXHEALTH vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Max Healthcare Institute P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Deccan Health Care | DECCAN | 12.18 | 0.25 | ₹27 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
| One Global Service Provi… | ONEGLOBAL | 17.94 | 11.02 | ₹1,165 |
| Fortis Healthcare | FORTIS | 65.48 | 6.81 | ₹64,009 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.